Cytokinetics Inc. buy Barclays PLC
Start price
06.04.26
/
50%
€55.52
Target price
06.04.27
€82.47
Performance (%)
21.97%
Price
20:08
€69.36
Summary
This prediction is currently active. The prediction currently has a performance of 21.97%. This prediction currently runs until 06.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 12.995% | 12.995% |
| iShares Core DAX® | 1,35 % | 0,93 % |
| iShares Nasdaq 100 | 3,28 % | 4,99 % |
| iShares Nikkei 225® | 7,43 % | 16,60 % |
| iShares S&P 500 | 1,70 % | 2,24 % |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Barclays PLC from $87.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
127.86%
09.05.26
09.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
63.39%
25.04.26
25.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25